These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Procainamide in acute myocardial infarction: a study on two different tablet preparations of sustained release type. Ihlen H; Ditlefsen L Curr Ther Res Clin Exp; 1975 Nov; 18(5):720-6. PubMed ID: 812650 [No Abstract] [Full Text] [Related]
8. Predicting plasma procainamide concentrations resulting from a sustained-release preparation. DiPersio DM; Chow MS Clin Pharm; 1985; 4(2):186-91. PubMed ID: 3987218 [TBL] [Abstract][Full Text] [Related]
9. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients. Kalin ML; Babich MF; Klinke WP; Hui WK Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989 [TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic comparison of two sustained-release oral procainamide preparations. Hore P; Bones P; Rollinson T; Ikram H Br J Clin Pharmacol; 1979 Sep; 8(3):267-71. PubMed ID: 497093 [TBL] [Abstract][Full Text] [Related]
11. [Steady-state plasma and saliva concentrations of procainamide and N-acetyl-procainamide after a sustained release preparation]. Pirovino M; Karlaganis G; Galeazzi RL Schweiz Med Wochenschr; 1980 Sep; 110(39):1415-9. PubMed ID: 6169144 [TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia following sustained-release procainamide. Meisner DJ; Carlson RJ; Gottlieb AJ Arch Intern Med; 1985 Apr; 145(4):700-2. PubMed ID: 2580499 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a sustained release procainamide preparation. Flanagan AD Angiology; 1982 Feb; 33(2):71-7. PubMed ID: 7039427 [TBL] [Abstract][Full Text] [Related]
14. Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets. Arstila M; Katila M; Sundquist H; Anttila M; Pere E; Tikkanen R Acta Med Scand; 1974 Mar; 195(3):217-22. PubMed ID: 4595254 [No Abstract] [Full Text] [Related]
15. Comparative bioequivalence and efficacy of two sustained-release procainamide formulations in patients with cardiac arrhythmias. Hilleman DE; Patterson AJ; Mohiuddin SM; Ortmeier BG; Destache CJ Drug Intell Clin Pharm; 1988; 22(7-8):554-8. PubMed ID: 2458219 [TBL] [Abstract][Full Text] [Related]
16. Procaineamide blood levels after administration of a sustained-release preparation. Cunningham E; Sloman G Med J Aust; 1977 Mar; 1(11):370-2. PubMed ID: 870815 [TBL] [Abstract][Full Text] [Related]
17. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)]. Bliddal J Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996 [No Abstract] [Full Text] [Related]
18. Sustained-release procainamide: use of serum concentrations to determine dosage. Reed WE; Cooper MW South Med J; 1985 Oct; 78(10):1190-3. PubMed ID: 4049036 [TBL] [Abstract][Full Text] [Related]
19. Clinical use of sustained-release procainamide in treatment of cardiac arrhythmias. Michelson EL; McGeehin FC; Levin BK Angiology; 1988 Jul; 39(7 Pt 2):647-54. PubMed ID: 3044199 [TBL] [Abstract][Full Text] [Related]
20. Plasma levels of procaine amide after administration of conventional and sustained-release tablets. Karlsson E Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151 [No Abstract] [Full Text] [Related] [Next] [New Search]